Mesa Laboratories Inc. (MLAB)
The price, the headline numbers and the latest news, in one place.
Mesa Laboratories Inc. (MLAB) Stock Price, Analysis & Data
| Bid | 87.9 |
| Market Cap | 698.14M |
| Revenue (ttm) | 249.72M |
| Net Income (ttm) | 4.8M |
| 0.93 | |
| 0.85 | |
| 146.78 | |
| 12.15 | |
| P/B (ttm) | 3.70 |
| P/S (ttm) | 2.80 |
| Earnings Date | Nov 5, 2026 |
| Ask | 153.98 |
| Volume | 137,854 |
| Avg. Volume (20D) | 204,425 |
| Open | 119.94 |
| Previous Close | 119.15 |
| Day's Range | 119.03 - 124.89 |
| 52-Week Range | 58.83 - 124.89 |
| Analyst | Buy |
| Price Target | 117.5 (-5.82%) |
| Dividends | $0.64 (0.51%) |
| Ex-Dividend Date | Aug 31, 2026 |
About MLAB
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical devic...
Financial Performance
In 2026, Mesa Laboratories's revenue was 249.13M, an increase of 3.38% compared to the previous year's 240.98M. Earnings were 6.71M, a decrease of -440.02%.
Financial StatementsAnalyst Forecast
According to 2 analyst ratings, the average rating for MLAB stock is "Buy". The 12-month stock price forecast is 117.5, which is downside of 5.82% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $63.72M misses estimates by $0, with 2.56% YoY growth.
- EPS of 1.3 misses estimates by -1.25, with -30.85% YoY decline.
Analysts project revenue of ... Upgrade
